Vaxcyte Inc. Common Stock vs W.R. Berkley Corporation Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B), while W.R. Berkley Corporation Common Stock trades at $74.25 (market cap $27.30B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 2.6× Vaxcyte Inc. Common Stock's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.
| PCVX | WRB | |
|---|---|---|
Market Cap | $10.51B | $27.30B |
Volume | 2,644,694 | 2,293,079 |
Sector | Health | Financials |
52-Week High | $73.82 | $78.10 |
52-Week Low | $40.32 | $63.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $27.54B |
Dividend Yield | — | 0.54% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.
Read more on WRB →